Completed Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma NCT03046953 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more Locations University College London Hospital — London, United Kingdom View Trial Details
Completed Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) NCT02689453 Conditions Adult T-Cell Leukemia (ATL), Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +21 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
